K. Bertelsen - Concepedia

Author

K. Bertelsen

Also Known As

K BERTELSEN, K Bertelsen, K. BERTELSEN, K. Bertelsen, KAMMA BERTELSEN, Kamma Bertelsen, Kiki Bjørnholdt Bertelsen, X. Xie

100

Publications

3.8K

Citations

H-Index

Concepts

All Affiliations

Odense University Hospital Aarhus University Hospital Aalborg University Hospital Vejle Sygehus Danish Cancer Society

About

K. Bertelsen is an author at Odense University Hospital specializing in oncology, medicine, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	33	2.2K
2	Obstetrics	18	25	1.9K
3	Health Sciences	5	5	155
4	Public Health	2	2	64
5	Social Sciences	1	1	43

K. Bertelsen

Publications

3.6K

Citations

H-Index

Page 1

	Year	Citations
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma Ignace Vergote, Jos De Brabanter, Anthony Fyles, The Lancet MedicineSurgical PathologyEpithelial Ovarian CarcinomaPathologyGynecology	2001	626
Postoperative radiotherapy in Dukes' B and C carcinoma of the rectum and rectosigmoid: A randomized multicenter study Ib Balslev, Mogens Pedersen, Finn Hanberg-Soerensen, Cancer	1986	265
Advanced epithelial ovarian cancer: 1993 consensus statements Darlene Allen, J. Baak, D Belpomme, Annals of Oncology Gynecological SurgeryMedicineGynecologyConsensus StatementsOncology	1993	185
A Prospective Randomized Comparison of 6 and 12 Cycles of Cyclophosphamide, Adriamycin, and Cisplatin in Advanced Epithelial Ovarian Cancer: A Danish Ovarian Study Group Trial (DACOVA) K. Bertelsen, Anders Jakobsen, I. Strøyer, Gynecologic Oncology MedicineMetronomic TherapyGynecologyProspective Randomized ComparisonCancer Treatment	1993	154
Dose-effect study of carboplatin in ovarian cancer: a Danish Ovarian Cancer Group study. Anders Jakobsen, K. Bertelsen, Jørn Andersen, Journal of Clinical Oncology	1997	144
Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer Jens Steen Nielsen, Erik Jakobsen, K. Bertelsen, International Journal of Gynecological Cancer	2004	141
Tumor reduction surgery and long-term survival in advanced ovarian cancer: A DACOVA study K. Bertelsen Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryAdvanced Ovarian CancerTumor Reduction Surgery	1990	141
Advanced epithelial ovarian cancer: 1998 consensus statements. Jonathan S. Berek, K. Bertelsen, Andreas du Bois, Annals of Oncology	1999	124
Long-term follow-up confirms a survival advantage of the paclitaxel-cisplatin regimen over the cyclophosphamide-cisplatin combination in advanced ovarian cancer Martine Piccart, K. Bertelsen, Gavin Stuart, International Journal of Gynecological Cancer	2003	122
A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinoma K. Bertelsen, Anders Jakobsen, Jørn Andersen, Gynecologic Oncology Randomized StudyMedicineMetronomic TherapyGynecologyAdvanced Ovarian Carcinoma	1987	115

Page 1